Probiotics in the gastrointestinal diseases of the elderly. (Q34637436)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Probiotics in the gastrointestinal diseases of the elderly (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Antonio Mistretta

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

G Malaguarnera

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

F Leggio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

M Motta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

M Giordano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

A Bondi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

F Basile

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

S Mastrojeni

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

M Malaguarnera

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

M A Toscano

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

M Salmeri

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

1 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Nutrition, Health and Aging

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

402-410

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12603-011-0357-1

28 January 2020

exact match

0 references

cites work

Variation in human intestinal microbiota with age.

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Probiotic properties of lactic-acid bacteria: plenty of scope for fundamental R & D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

The role of the gut microbiota in energy metabolism and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Conjugated linoleic acid biosynthesis by human-derived Bifidobacterium species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Immunosenescence: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

The role of immunity in elderly cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Immunosenescence and cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Immunosenescence and anti-immunosenescence therapies: the case of probiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Prevention of travellers' diarrhoea by Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Meta-analysis of probiotics for the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Epidemiology, risk factors and treatments for antibiotic-associated diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Diverticular disease and diverticulitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

The burden of selected digestive diseases in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Review article: uncomplicated diverticular disease of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

The host-microbe interface within the gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Prevalence of Celiac disease among children in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Structural basis for gluten intolerance in celiac sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Celiac disease: current concepts in diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Sourdough lactobacilli and celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Adjuvant effect of Lactobacillus casei in a mouse model of gluten sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Nonlipopolysaccharide component(s) of Lactobacillus acidophilus stimulate(s) the production of interleukin-1 alpha and tumor necrosis factor-alpha by murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Saccharomyces boulardii in maintenance treatment of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

The role of lactic acid bacteria in colon cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Functional food science and gastrointestinal physiology and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Probiotics improve bowel movements in hospitalized elderly patients--the PROAGE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

21 January 2018

12 December 2020

Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Habitual Intake of Lactic Acid Bacteria and Risk Reduction of Bladder Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-011-0357-1

Prevention of colon cancer: role of short chain fatty acids produced by intestinal flora

21 January 2018

1 reference

12 December 2020

Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria

1 reference

12 December 2020

Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers

1 reference

12 December 2020

1 reference

12 December 2020

Improvement of nutritional status and incidence of infection in hospitalised, enterally fed elderly by feeding of fermented milk containing probiotic Lactobacillus johnsonii La1 (NCC533)

1 reference

12 December 2020

Turbo probiotics for IBD

1 reference

12 December 2020

Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora

1 reference

12 December 2020

Human Fecal Flora: The Normal Flora of 20 Japanese-Hawaiians

1 reference

12 December 2020

Incrimination of anaerobic bacteria in the induction of experimental colitis

1 reference

12 December 2020

Diverticular disease of the colon

1 reference

12 December 2020

Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome

1 reference

12 December 2020

Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection

1 reference

12 December 2020

Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink

1 reference

12 December 2020

Probiotics in diverticular disease of the colon: an open label study.

1 reference

12 December 2020

Short-chain fatty acids produced by intestinal bacteria

1 reference

12 December 2020

Clinical Results of a Multicenter Study with Sulbactam/Ampicillin for the Treatment of Patients with Lower Respiratory and Urinary Tract Infections

1 reference

12 December 2020

Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study

1 reference

12 December 2020

Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota

1 reference

12 December 2020

Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea.

1 reference

12 December 2020

Role of nutrients and bacterial colonization in the development of intestinal host defense.

1 reference

12 December 2020

Systematic review: the management of pouchitis

1 reference

12 December 2020

Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities

1 reference

12 December 2020

Systematic review of randomised controlled trials: probiotics for functional constipation

1 reference

12 December 2020

Long-term treatment with rifaximin and lactobacilli in post-diverticulitic stenoses of the colon

1 reference

12 December 2020

Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection

1 reference

12 December 2020

The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer

1 reference

12 December 2020

Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study

1 reference

12 December 2020

Lactobacillus- and bifidobacterium-mediated antigenotoxicity in the colon of rats

1 reference

12 December 2020

Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN001.

1 reference

12 December 2020

Modulation of the immune response by probiotic strains in a mouse model of gluten sensitivity

1 reference

12 December 2020

Lactobacilli to prevent traveler's diarrhea?

1 reference

12 December 2020

Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis

1 reference

12 December 2020

10.1007/S12603-011-0357-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22499466%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

28 January 2020

1052961573

0 references

Fatcat ID

release_ugpoqejtivhhbcuewgznti5woq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ugpoqejtivhhbcuewgznti5woq

24 November 2022

mapped directly with Wikidata item

1 reference